Clinical trial
Prospective, Non-interventional Study to Evaluate the Efficacy and Safety of NOVOCART® 3D for the Treatment of Cartilage Defects of the Knee in Pediatric Patients With Closed Epiphyses
NCT04186208 is registered in ClinicalTrials.gov with Tetec AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Non-interventional Study to Evaluate the Efficacy and Safety of NOVOCART® 3D for the Treatment of Cartilage Defects of the Knee in Pediatric Patients With Closed Epiphyses
- Lead sponsor
- Tetec AG
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- April 25, 2017
- Completion date
- June 30, 2026
- Enrollment
- 42 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
cartilage disease